Evaluate AQST stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in AQST? | Glauxie AI

Q: What are the risks of investing in AQST?

Aquestive Therapeutics, Inc. (AQST) operates in the Drug Manufacturers - Specialty & Generic industry (Healthcare sector). The company is led by CEO Daniel Barber. Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and... Employees: 151.

Q: How much debt does AQST have?

Review AQST total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is AQST a good long-term investment?

Evaluate AQST as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in AQST?

🦉

Aquestive Therapeutics, Inc. (AQST)

Company Overview

Sector / IndustryHealthcare / Drug Manufacturers - Specialty & Generic

CEODaniel Barber

Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of...

Key Executives

Name	Title
A. Ernest Toth Jr.	Senior VP & CFO
Cassie Jung	Chief Operating Officer
Daniel Barber	Chief Executive Officer, President & Director
Lori J. Braender BSBA	Corporate Secretary
Matthew Greenhawt	Chief Medical Officer
Matthew William Davis	Chief Development Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

AQST Profile Financials

Is AQST stock safe? How much debt does AQST have? Is AQST a good long-term investment?